We all want to know our DNA
-
People are curious about their DNA because it can reveal personal health risks and ancestry. But many hesitate to consider genetic testing because the results can be confusing, they’re unsure how useful the information will be, and they worry about privacy.
-
Unclear benefits also make people hold back from taking the test.
Bridging the last mile in genomics
Complexity of Interpretation
Most hospitals and health systems struggle to make sense of the growing volume of genetic test data - especially when results involve complex layers like monogenic mutations, polygenic risk, and pharmacogenomics. It takes time, expertise, and resources that many clinical teams simply don’t have.
Uneven Access to Genomic Insights
Due to differences in how much genetic testing has been done across different ethnic groups, people from minority backgrounds often get fewer answers from genetic tests compared to people of European descent. This means millions of people, especially Black, Hispanic, Asian, and mixed-ancestry individuals, receive inconclusive results.
Lack of Usability at the Point of Care
Even when test results are available, they’re often too technical for non-specialists to understand or use. Primary care teams and patients are left with unclear information, limiting the potential of personalized medicine
Point of Care
We’ve developed, and continue to refine, a regulatory-compliant, AI-assisted, manually verified lay-language reporting system.
The Nova Reporting System enables primary care teams to deliver a deeper, more precise view of personal disease risk and preventive opportunities, empowering clinicians to make informed decisions tailored to each individual.
1. Simplify Clinical Interpretation Nova uses AI to assist trained professionals by simplifying multilayered genetic test results into easier-to-understand summaries. These summaries are designed to support, not replace, medical judgment, enabling clinicians to work faster and more confidently in diagnosis, prognosis, and treatment planning. ✦ Provides layered summaries of monogenic, polygenic, and pharmacogenomic data ✦ Helps providers connect genetic findings to clinical action - without requiring expert genetics training Our AI does not diagnose - it explains and help patients visualize findings reviewed by professionals
2. More Meaningful Results for More Patients from All Backgrounds Facts ✦ A person of African, Hispanic or Asian descent may receive 2 to 4 times more "variants of uncertain clinical significance" (meaning: Not sure if this gene change matters yet) than someone of European descent. ✦ Similarly, people from some ethnic backgrounds also may get uncertain polygenic risk scores, just because there’s less genetic research data available. Solutions Nova and Galatea are making genetic testing fairer. We’re helping close that gap by adjusting our genetic risk tools specific to particular ethnic groups, to better reflect your unique ancestry. ✦ For example, having a breast cancer gene doesn’t always mean you will get cancer - that is called incomplete penetrance. ✦ But if we add your polygenic risk analysis (which looks at many small-risk genes across your DNA), accurately adjusted for your ancestry using our validated methods, it can show whether your overall risk is higher. ✦ Your family background plays a big role in genetic risk assessment. For example, if your heritage includes European, Asian, and Black roots, we tailor the analysis to match your unique mix - making your results more accurate and useful for your health, and helping us better serve our diverse population. Your finely-tuned risk help doctors decide if screening, prevention, or lifestyle choices may be best for you.
3. Making Genetics Work at the Point of Care Even when genetic test results are available, they are often too technical, abstract, or culturally disconnected to be meaningful for primary care teams, patients and families, especially in diverse communities. Primary care teams ✦ We provide one-page physician summaries to meet the needs of primary care providers and frontline specialists, by focusing on what the result means, instead of overwhelming clinicians with mutation nomenclature. ✦ Simplified management path helps non-genetics-trained providers quickly grasp the diagnosis or risk assessment with actionable steps. Patients ✦ We explain genetic findings in plain, compassionate language, accessible and respectful to diverse populations. ✦ When patients are more well-informed, they are less likely to misinterpret uncertain results, less likely to seek unnecessary screening, and more likely to engage in shared, informed decision making. ✦ By doing this well, we also reduce physicians' counseling burden.
What’s in our reports
Clinically-Backed
Clear
Empowering
What we provide
Genetic Tests
from
CLIA-certified & CAP-accredited
Clinical Testing Laboratories
Obtain a Genetic Diagnosis
Clear, Ethnic-Specific Educational Reports
One-Page Physician Note
Multi-Lingual
for Diverse Populations
Deeper Understanding
For Patients & Families
Simple is Powerful